公司資料
Evolent Health 股價、新聞與催化劑
- 股票代碼:
- EVH
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.39 USD (-2.87%)
收盤價
最後更新: 2026年10月1日
445M USD
市值
股價為何變動
截至 2026年10月1日，EVH 下跌 2.87%，收於 $3.39。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Specialty Care Management Company
Evolent Health helps health plans and risk-bearing providers manage care for people with complex conditions. Its programs are designed to improve clinical outcomes while lowering medical expense in high-cost specialty categories.
Oncology and Complex-Care Solutions
The company provides specialty management capabilities in oncology and other areas such as cardiology and musculoskeletal care. Services include evidence-based treatment pathways, utilization management, provider engagement, and care coordination.
Performance-Based Contracting
Evolent uses multi-year contracts that can include administrative fees, risk-sharing, or total-cost-of-care arrangements. This model aligns part of the company's economics with medical-cost and quality outcomes achieved for clients.
Technology and AI-Enabled Operations
Clinical data, workflow software, analytics, and AI-enabled operating tools support authorization decisions, member identification, provider communication, and program measurement. The platform is designed to integrate with payer and provider systems rather than replace them.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。